Pathology of ANCA-associated vasculitis

被引:24
|
作者
Ferrario, Franco [1 ]
Vanzati, Alice [1 ]
Pagni, Fabio [1 ]
机构
[1] Univ Milano Bicocca, Nephropathol Unit, Dept Pathol, San Gerardo Hosp, I-20900 Monza, Italy
关键词
ANCA-associated vasculitis; MPA; GPA; EGPA; SYSTEMIC VASCULITIS; RENAL INVOLVEMENT; GLOMERULONEPHRITIS;
D O I
10.1007/s10157-012-0701-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
According to the recent 2012 Chapel Hill Consensus Conference, ANCA-associated vasculitis is classified in the group of small vessel vasculitis. Pauci-immune necrotizing crescentic glomerulonephritis is the morphological hallmark of ANCA-associated vasculitis. Crescentic damage of the glomerular tuft is characterized by macrophage accumulation through vascular cell adhesion molecule-1 (VCAM-1) activation. Macrophages have a key role in chronic progression of renal damage due to production of substances involved in matrix remodelling [transforming growth factor-beta (TGF beta)]. Diffuse interstitial infiltration of T and B lymphocytes and macrophages is another frequent morphological feature. Tubulitis is considered an important marker of worse prognosis. Unfortunately, the renal changes on long-term follow-up are largely unknown due to the small number of studies with repeat biopsy in these disorders. Although a standardized score for renal biopsies was developed previously, a final histopathologic classification is still lacking. The European Vasculitis Study Group (EUVAS) proposed a classification system based on glomerular pathology as assessed by light microscopy.
引用
收藏
页码:652 / 658
页数:7
相关论文
共 50 条
  • [41] Pathogenesis of ANCA-associated Vasculitis
    Flint, Julia
    Morgan, Matthew D.
    Savage, Caroline O. S.
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (03) : 463 - +
  • [42] Biomarkers in ANCA-Associated Vasculitis
    Lally, Lindsay
    Spiera, Robert F.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (10)
  • [43] Comorbidities in ANCA-associated vasculitis
    Kronbichler, Andreas
    Leierer, Johannes
    Gauckler, Philipp
    Shin, Jae Il
    [J]. RHEUMATOLOGY, 2020, 59 : 79 - 83
  • [44] Immunosuppression in ANCA-associated vasculitis
    van der Woude, FJ
    Schmitt, WH
    Birck, R
    Nowack, R
    Göbel, U
    Drexler, JM
    Hotta, O
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2225 - 2226
  • [45] Spectrum of ANCA-Associated Vasculitis
    Sinha, Aditi
    Bagga, Arvind
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2017, 84 (10): : 737 - 738
  • [46] Biomarkers in ANCA-Associated Vasculitis
    Lindsay Lally
    Robert F. Spiera
    [J]. Current Rheumatology Reports, 2013, 15
  • [47] Rituximab in ANCA-Associated Vasculitis
    Romina I. Hassan
    Angelo L. Gaffo
    [J]. Current Rheumatology Reports, 2017, 19
  • [48] Treatment of ANCA-associated vasculitis
    Ulf Schönermarck
    Wolfgang L. Gross
    Kirsten de Groot
    [J]. Nature Reviews Nephrology, 2014, 10 : 25 - 36
  • [49] Rituximab in ANCA-Associated Vasculitis
    Hassan, Romina I.
    Gaffo, Angelo L.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (02)
  • [50] The immunopathology of ANCA-associated vasculitis
    Eoin F. McKinney
    Lisa C. Willcocks
    Verena Broecker
    Kenneth G. C. Smith
    [J]. Seminars in Immunopathology, 2014, 36 : 461 - 478